March 23 (UPI) -- Biotech company Moderna announced on Wednesday that smaller doses of its COVID-19 vaccine have proven to be highly effective in protecting small children, including babies, from the coronavirus.
Moderna said results from a late-stage study have demonstrated that the child-sized vaccine doses work well in children between 6 months and 6 years old. The studies included almost 7,000 children in that age range in the United States and Canada.